Your browser doesn't support javascript.
loading
Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study.
Pozo-Rosich, Patricia; Detke, Holland C; Wang, Shufang; Dolezil, David; Li, Lily Q; Aurora, Sheena K; Reuter, Uwe.
Afiliação
  • Pozo-Rosich P; Headache Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Detke HC; Headache and Neurological Pain Research Group, Vall d'Hebron Institute of Research (VHIR), Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Wang S; Eli Lilly and Company, Indianapolis, IN, USA.
  • Dolezil D; Eli Lilly and Company, Indianapolis, IN, USA.
  • Li LQ; Now at Sarepta Therapeutics, Cambridge, MA, USA.
  • Aurora SK; Prague Headache Center, DADO MEDICAL s.r.o, Prague, Czech Republic.
  • Reuter U; Eli Lilly and Company, Indianapolis, IN, USA.
Curr Med Res Opin ; 38(5): 731-742, 2022 05.
Article em En | MEDLINE | ID: mdl-35392739
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos de Enxaqueca Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos de Enxaqueca Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article